Clinical Pipeline

Our clinical-stage pipeline includes product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics.

Click on the potential products in the chart for compound information.
Click on the pipeline arrow for clinical information on each trial.

	IND-Enabling Studies	Safety/Dosing Studies	Efficacy Studies
Azixa™ Brain Cancer
MPC-3100 Cancer
MPC-9528 Cancer
MPI-485520 Cancer and Inflammation
MPI-443803 Brain Cancer
MPI-487109 Cancer